Cancer Antigen 27-29

Last Modified: 7/19/2019 4:08:45 PM

  Medicare Medical Necessity Restrictions May Apply
Medical Necessity Documentation:  
Client Notes:  
Patient Preparation:  
Specimen Requirements: 1.0 mL Serum in a SST Gold Top Tube
Collection Instructions:  
Minimum Volume: 0.5 mL
Transport & Storage: Temperature/Stability: 7 days Ambient (transport)
7 days Refrigerated
28 days Frozen

24 hours unspun
Rejection Criteria: Gross hemoloysis
Reference Range:

<38 U/mL

Critical Ranges:  
Test Comments: This test was performed using the Siemens Chemiluminescent method. Values obtained from different assay methods cannot be used interchangeably. CA 27.29 levels, regardless of value, should not be interpreted as absolute evidence of the presence or absence of disease.
Methodology: Immunoassay (IA)
Clinical Significance: CA 27.29 may be useful for monitoring patients for metastatic breast cancer.
Documentation: CA 27.29 is not intended as a screening test.
Custom Panel: No


Turn Around Time: 2 to 3 days
Days Performed: Monday, Tuesday, Wednesday, Thursday, Friday, Saturday
Sites Performed: Quest - Chantilly
PHL Test Code: C2729
EPIC Test Code: IMO422
Send Out Test Code: 29493
Alternate Test Names: CA 27.29; CA 27-29
Included Tests:  
CPT Coding: 86300

Go back to the top of the page.